Ak Pharmaceuticals Private Limited
About Ak Pharmaceuticals Private Limited
Data last updated:
Ak Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 03 November 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL1998PTC096905. Its GSTIN is 09AABCA9117C1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.05 Lakh. It is led by directors including Sunil Bansal and Thakur Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 130 New Venus Apartments Plot No.43 Rohini Sector 9, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.76 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹8,559 (net margin 0.8%) and EBITDA of ₹43,580 (EBITDA margin 4.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ak Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressT – 130 New Venus Apartments Plot No.43 Rohini Sector 9, New Delhi, Delhi, India – 110085
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Ak Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ak Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ak Pharmaceuticals Private Limited, buy the company report.
Financials of Ak Pharmaceuticals Private Limited
FY 2025 filings availableAk Pharmaceuticals Private Limited reported revenue of ₹10.76 Lakh (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 22% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43,580 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,559 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ak Pharmaceuticals Private Limited
Ak Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Bansal | Director | 03 Nov 1998 | 27 Years 11 Months | Current |
| Thakur Das | Director | 03 Nov 1998 | 27 Years 11 Months | Current |
| Anil Kumar | Director | 03 Nov 1998 | 27 Years 11 Months | Current |
| Kavita Rani | Director | 03 Nov 1998 | 27 Years 11 Months | Current |
Peer comparison
Ak Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medstream Pharmaceuticals (India) Private Limited | ₹10.76 Lakh (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Ak Pharmaceuticals Private Limitedthis company | ₹10.76 Lakh (FY 2025) | ₹8,559 | 0.8% | 22.0% | New Delhi, Delhi, India | |
| Gabreal Pharmaceuticals Pvt Ltd | ₹10.73 Lakh (FY 2023) | -8.0% | Dombivli, Maharashtra, India | |||
| Lukem Pharmaceuticals Private Limited | ₹10.73 Lakh (FY 2025) | -30.0% | Patna, Bihar, India | |||
| Shinewell Pharmaceuticals Private Limited | ₹10.69 Lakh (FY 2024) | 2.0% | Nalasopara West, Maharashtra, India |
To see the full peer comparison of Ak Pharmaceuticals Private Limited, buy the company report.
Auditor
Ak Pharmaceuticals Private Limited is audited by R MITTAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R MITTAL & CO. | FY 2023 | 070137 |
Shareholding
The shareholding of Ak Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ak Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ak Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ak Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCA9117C1ZZ | Uttar Pradesh | Active | 27 Jul 2017 |
To see the full GST registrations and return filing status of Ak Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ak Pharmaceuticals Private Limited has 5 board changes on record since 1998: 4 appointments and 1 cessation. The latest: Thakur Das ceased to be Director on 18 Nov 2024.
Frequently asked questions
Ak Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 03 November 1998 (28+ years old) and is registered under CIN U24233DL1998PTC096905.
Ak Pharmaceuticals has 4 current directors:
- Sunil Bansal - Director
- Thakur Das - Director
- Anil Kumar - Director
- Kavita Rani - Director
The latest financial statements of Ak Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ak Pharmaceuticals is 09AABCA9117C1ZZ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ak Pharmaceuticals is U24233DL1998PTC096905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ak Pharmaceuticals was incorporated on 03 November 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ak Pharmaceuticals by revenue are Medstream Pharmaceuticals (India) Private Limited, Gabreal Pharmaceuticals Pvt Ltd, Lukem Pharmaceuticals Private Limited, Shinewell Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading).
Thakur Das ceased to be Director on 18 Nov 2024. Anil Kumar was appointed as Director on 03 Nov 1998. Kavita Rani was appointed as Director on 03 Nov 1998. Ak Pharmaceuticals has 5 board changes on record in total.
The registered office of Ak Pharmaceuticals is at T – 130 New Venus Apartments Plot No.43 Rohini Sector 9, New Delhi, Delhi, India – 110085.
Ak Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.
The compliance status of Ak Pharmaceuticals is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.